Virelion
Tools Talk to us

FAQ

Programs, tools, collaboration, and research-stage status.

Are you a clinical-stage company?

No. VB-101 is in candidate identification, VB-204 in discovery, and VB-310 (HeartTwin) in active platform development. There are no clinical trials and no approved products.

Can I use the tools in a clinical workflow?

No. Public tools are research software for lab planning, measurement, and computational experiments , not clinical decision support or medical devices.

How do I cite the software or architecture release?

Cite the Zenodo architecture record (DOI 10.5281/zenodo.22680867) and the specific GitHub repository and version used. Individual tool READMEs may list preferred citations.

Where do I start with the computational stack?

Start with Virelion-HeartTwin as the orchestration entrypoint, then the specialist repos it registers (ElectroTrace, MyoTrace, OptiCell, CardioScore, CardiSim, and others).

Do you have patents?

No public patents are listed yet. Filings will be disclosed on the About page when available.

How can labs or clinicians collaborate?

Email virelion85@gmail.com with a short description of the overlap and any relevant program ID (VB-101 / VB-204 / VB-310). See also the collaborate page.

Are you hiring?

No formal open roles are listed. Brief intros by email are welcome.

What about dual-use and biosafety?

Public safety tools (e.g. Biosafety Assessment, CardioScore) are planning and research aids based on public guidance. They do not replace institutional biosafety review or regulatory requirements.

Is HeartTwin a clinical digital twin?

No. HeartTwin is research infrastructure with a native digital-twin backend for software integration and evaluation. It does not diagnose or treat patients.